Correlation Between Unicycive Therapeutics and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Virax Biolabs Group, you can compare the effects of market volatilities on Unicycive Therapeutics and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Virax Biolabs.
Diversification Opportunities for Unicycive Therapeutics and Virax Biolabs
0.12 | Correlation Coefficient |
Average diversification
The 3 months correlation between Unicycive and Virax is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Virax Biolabs go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Virax Biolabs
Given the investment horizon of 90 days Unicycive Therapeutics is expected to under-perform the Virax Biolabs. But the stock apears to be less risky and, when comparing its historical volatility, Unicycive Therapeutics is 1.84 times less risky than Virax Biolabs. The stock trades about -0.09 of its potential returns per unit of risk. The Virax Biolabs Group is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 189.00 in Virax Biolabs Group on October 20, 2024 and sell it today you would earn a total of 29.00 from holding Virax Biolabs Group or generate 15.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Virax Biolabs Group
Performance |
| Timeline |
| Unicycive Therapeutics |
| Virax Biolabs Group |
Unicycive Therapeutics and Virax Biolabs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Virax Biolabs
The main advantage of trading using opposite Unicycive Therapeutics and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |